Background And Purpose: Stereotactic radiotherapy (SRT, SBRT) is widely used in oligometastatic cancer, but the heterogeneity of the population complicates estimation of the prognosis. We investigated the role of different clinical and inflammatory parameters.
Materials And Methods: We included all patients treated with SRT for 1-5 oligometastases between 2003 and 2017 in our center.